21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
METHODS AND COMPOSITIONS RELATING TO ASSESSMENT FOR INFERTILITY
#6902DNA Damage Repair Deficit in Cancer Cells
#6903OLIGONUCLEOTIDES
#6904Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
#6905OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP
#6906METHODS FOR TREATING GLIOBLASTOMA
#6907METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL INFECTION
#6908USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS
#6909DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING C5-MEDIATED GLOMERULAR NEPHRITIS (GN), INCLUDING LUPUS NEPHRITIS (LN) AND/OR IGA NEPHROPATHY (IGAN)
#6910Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
#6911NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#6912NOVEL T-CELL SPECIFICITIES AND USES THEREOF
#6913SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE
#6914Heteroaryl inhibitors of PDE4
#6915A COMPOUND HAVING INHIBITORY ACTIVITY AGAINST KRAS G12D MUTATION
#6916MCL1 inhibitors
#6917CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF
#6918NLRP3 MODULATORS
#69191-((1H-PYRAZOL-4-YL)METHYL)-3-(PHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS GPR139 ANTAGONISTS FOR THE TREATMENT OF E.G. DEPRESSION
#6920PLASMA KALLIKREIN INHIBITORS
#6921BIAMINOQUINOLINES AND NANOFORMULATIONS FOR CANCER TREATMENT
#6922CRYSTALLINE 5-METHOXY-N,N-DIALLYLTRYPTAMINE COMPOUNDS
#6923PURE FORMS OF CRYSTALLINE ATICAPRANT
#6924LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS
#6925Biomimetic vesicles and uses thereof
#6926MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#6927METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS
#6928METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN AND AGGREGATE THEREOF
#6929Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
#6930Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)
#6931METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION
#6932COMPOSITIONS FOR AND METHODS OF TREATMENT WITH MUTANT A1 ADENOSINE RECEPTOR PLASMID cDNAs
#6933METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#6934Enhanced Mediterranean Diet-Based Nutritional Compositions And Methods
#6935TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION
#6936FORMULATION FOR MANAGEMENT OF POST-ORAL SURGICAL RECOVERY AND MAINTENANCE OF ORAL HEALTH
#6937CANCER ERADICATING - BIO-NANOPARTICLES (CE-BNP)
#6938Therapeutic Bacterial Composition
#6939JUVENILE PROTECTIVE FACTORS TO ARREST AND REVERSE AGING IN THE ENTERIC NERVOUS SYSTEM
#6940METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE
#6941COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTION
#6942LMP7-SELECTIVE INHIBITORS FOR THE TREATMENT OF BLOOD DISORDERS AND SOLID TUMORS
#6943USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
#6944USE OF AGENTS FOR TREATMENT OF RESPIRATORY CONDITIONS
#6945Use of zinc porphyrin as an antimicrobial
#6946INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS
#6947Dosing regimen for sedation with CNS 7056 (Remimazolam)
#6948Administration and dosage of diaminophenothiazines
#6949Compositions and Methods for Treating SARS-CoV-2
#6950ATR INHIBITORS FOR THE TREATMENT OF CANCER
#6951METHODS FOR TREATING VIRAL DISORDERS
#6952Organic compounds
#6953METHOD FOR TREATING COMPLEMENT MEDIATED DISORDERS CAUSED BY BETACORONAVIRUSES
#6954THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY
#6955USE OF SGC ACTIVATORS FOR THE TREATMENT OF OPHTHALMOLOGIC DISEASES
#6956USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA
#6957Nicotine lozenge
#6958REPURPOSING FDA-APPROVED DRUGS AS A NOVEL CANCER THERAPEUTIC AVENUE THROUGH INHIBITION OF PRMT5
#6959AGENTS TO PREVENT TISSUE DAMAGE FROM CLOSTRIDIUM DIFFICILE INFECTIONS BY INHIBITION OF THE GUT-DAMAGING BACTERIAL TOXINS TCDA AND TCDB
#6960NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
#69615HT AGONISTS FOR TREATING DISORDERS
#6962PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION CONTAINING GLUCOKINASE ACTIVATOR AND K-ATP CHANNEL BLOCKER, PREPARATION METHOD THEREFOR AND USE THEREOF
#6963ERIODICTYOL COMPOSITIONS AND METHODS
#6964COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF VIRUS INFECTIONS
#6965COMBINATION THERAPY OF ATRA OR OTHER RETINOIDS WITH IMMUNOTHERAPEUTIC AGENTS BINDING TO BCMA
#6966Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators
#6967BIOLOGICALLY ACTIVE SUBSTANCE UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME
#6968Antimicrobial and anti-inflammatory compositions
#6969Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
#6970Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
#6971METHOD OF TITRATING DOSE OF PSYCHEDELICS
#6972SYNERGISTIC ANTIBACTERIAL ACTIVITY OF MEDIUM POLARITY OILS IN COMBINATION WITH ANTIBACTERIAL AGENTS ON BACTERIAL BIOFILMS
#6973DISCONNECTION AGENTS
#6974METHODS FOR TREATING MULTIPLE MYELOMA AND THE USE OF COMPANION BIOMARKERS FOR 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE
#6975METHOD AND SYSTEM FOR DETECTING AND TREATING EXPOSURE TO AN INFECTIOUS PATHOGEN
#6976METHODS FOR MONITORING AND TREATING CANCER
#6977TREATMENT OF SKIN DISEASES AND DISORDERS USING INHIBITORS OF KALLIKREIN-RELATED PEPTIDASES (KLK)
#6978Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#6979Antibodies specific for GUCY2c and uses thereof
#6980METHOD FOR TREATING A GD2 POSITIVE CANCER
#6981COMPOSITIONS AND METHODS FOR TREATING CANCER
#6982METHODS AND COMPOSITIONS FOR CANCER TREATMENT BY INHIBITION OF FBXO44
#6983BTLA-BINDING ANTIBODIES FOR MODULATING IMMUNE RESPONSE AND TREATING DISEASE
#6984COMPOSITION OF TRIAX ANTIBODIES AND METHOD OF MAKING AND USING THEREOF
#6985ANTI-CD147 ANTIBODY
#6986NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS
#6987Misfolded TDP-43 Binding Molecules
#6988YEAST-BASED IMMUNOTHERAPY AGAINST CLOSTRIDIUM DIFFICILE INFECTION
#6989ANTIBODY-MEDIATED NEUTRALIZATION OF BETA-LACTAMASES
#6990ANTI-HBV ANTIBODIES AND METHODS OF USE
#6991TREATMENT OF HEREDITARY ANGIOEDEMA WITH LIVER-SPECIFIC GENE THERAPY VECTORS
#6992CHIMERIC ANTIGEN RECEPTOR (CAR) WITH CD28 TRANSMEMBRANE DOMAIN
#6993PEPTIDES AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#6994Immunogenic Compositions Against SARS-COV-2 Variants And Their Methods Of Use
#6995Treatments for Gastrointestinal Disorders
#6996DPAGT1 INHIBITORS OF CAPURAMYCIN ANALOGUES AND THEIR ANTIMIGRATORY ACTIVITIES OF SOLID TUMORS
#6997Processes for the preparation of soluble salts of inositol phosphates
#6998HYPOXIA-ACTIVATED DNA ALKYLATING AGENT AND MEDICAL USE THEREOF
#6999SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF
#7000Bridged tricyclic carbamoylpyridone compounds and uses thereof
#7001Bridged tricyclic carbamoylpyridone compounds and uses thereof
#7002Bicyclic-fused heteroaryl or aryl compounds
#7003Macrocyclic heterocycles and uses thereof
#7004THERAPEUTIC AGENTS AND METHODS OF TREATMENT
#7005HPK1 INHIBITORS AND USES THEREOF
#7006COMPOUNDS AND METHODS OF MODULATING 17B-HYDROXYSTEROID DEHYDROGENASE TYPE 13
#7007QUINAZOLINE-DERIVED HCK INHIBITORS FOR USE IN THE TREATMENT OF MYD88 MUTATED DISEASES
#7008METHODS AND COMPOSITIONS FOR REPAIR OF CARTILAGE USING AN IN VIVO BIOREACTOR
#7009METHOD OF TREATING PSMA-EXPRESSING CANCERS
#7010RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
#7011GALACTOSYLATED DENDRIMERS FOR TARGETED INTRACELLULAR DELIVERY TO HEPATOCYTES
#7012DELIVERY SYSTEM FOR TARGETED DELIVERY OF A THERAPEUTICALLY ACTIVE PAYLOAD
#7013GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM
#7014XANTHAN-BASED OPHTHALMIC TOPICAL FORMULATIONS WITH A REDUCED DOSAGE REGIMEN
#7015VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER
#7016Method of treating, reducing, or alleviating a medical condition in a patient
#7017Coronavirus vaccine
#7018Immune complex
#7019ALDH1 ANTIGEN-PULSED DENDRITIC CELLS
#7020USE OF INHALED INTERFERON-BETA TO IMPROVE OUTCOME IN SARS-CoV-2 INFECTED PATIENTS
#7021METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS
#7022Treatment for Diseases Caused by RNA Viruses
#7023COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
#7024PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL COMPRISING ORANGE-DERIVED EXTRACELLULAR VESICLES
#7025PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES
#7026Oncolytic viruses for modified MHC expression
#7027METHOD FOR TREATING AND/OR PREVENTING A PARASITIC INFECTION IN A TELEOST
#7028SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
#7029METHOD OF USING CYCLODEXTRIN
#7030COMPOSITIONS AND METHODS OF TREATMENT USING NICOTINAMIDE MONONUCLEOTIDE
#7031METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS IN INFANTS, TODDLERS, OR CHILDREN USING HUMAN MILK OLIGOSACCHARIDES
#7032TREATMENT FOR DEPRESSION
#7033DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#7034NOVEL USES
#7035AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
#7036MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOGIC NEOPLASM RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION
#7037COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN CONFORMATIONAL DISORDER
#7038TREATMENT OF PRURIGO NODULARIS
#7039COMBINATION CHEMO-IMMUNOTHERAPY FOR PANCREATIC CANCER USING THE IMMUNOGENIC EFFECTS OF AN IRINOTECAN SILICASOME NANOCARRIER PLUS ANTI-PD-1
#7040METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#7041Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase
#7042Androgen Receptor Inhibitors For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer In Subjects With Severe Hepatic Impairment
#7043NOVEL ANTI-AGING AGENTS AND METHODS TO IDENTIFY THEM
#7044Methods of Treating Cystic Fibrosis
#7045ORAL DISSOLVABLE FILM THAT INCLUDES PLANT EXTRACT
#7046Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
#7047KOJIC ACID DERIVATIVE AS SELECTIVE INHIBITOR OF MITOSIS IN COLORECTAL AND GLIOBLASTOMA CANCER CELLS
#7048METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY
#7049Compositions and methods for stimulating ventilatory and/or respiratory drive
#7050METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING
#7051METHODS FOR THE TREATMENT OF MYELOID DERIVED SUPPRESSOR CELLS RELATED DISORDERS
#7052Methods of treatment of cholestatic diseases
#7053ANTI-VIRAL THERAPY
#7054Encapsulated Agents that Bind to MCT-1
#7055Biodegradable polymer microsphere compositions for parenteral administration
#7056Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
#7057Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels
#7058Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
#7059METHOD OF TREATING CANCER
#7060MARKERS FOR DETECTING CARDIOVASCULAR DISEASE AND CARDIOVASCULAR DISEASE RISK
#7061Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof
#7062MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO
#7063POLYLYSINE POLYMERS WITH ANTIMICROBIAL AND/OR ANTICANCER ACTIVITY
#7064Method of Treating an Autoimmune Disease with Antagonistic CD40 Monoclonal Antibodies
#7065METHODS AND COMPOSITIONS FOR TREATING SYSTEMIC MASTOCYTOSIS
#7066OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION
#7067Methods of treating AL amyloidosis
#7068SARS-COV-2 ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE
#7069HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE
#7070ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS
#7071COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#7072Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof
#7073Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
#7074Processes for preparing a diazabicyclooctane compound
#7075SOLID FORMS OF (R)-1(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANECARBOXAMIDE
#7076CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF
#7077Fused Imidazole Derivatives as AHR Antagonists
#7078FAP-ACTIVATED COMPOUNDS FOR TREATMENT OF CANCER
#7079GSPT1 compounds and methods of use of the novel compounds
#7080Treprostinil derivative compounds and methods of using same
#7081Compounds and methods for the targeted degradation of androgen receptor
#7082NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF
#7083AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF
#7084COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS
#7085MODULATORS OF NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1 (NR4A1) AND USES THEREOF
#7086SELF-ASSEMBLED COMPLEX CONTAINING IRON ION
#7087Process for cure of MI's and strokes through drug induced biophysical methods.
#7088NY-ESO-1-CONTAINING ARTIFICIAL ADJUVANT VECTOR CELL FOR USE IN TREATMENT OF CANCER
#7089ENHANCEMENT OF STEM CELL THERAPY FOR CARTILAGE DEGENERATION BY ANTI-OXIDANT PRE-CONDITIONING
#7090USE OF GHRELIN OR GHRELIN VARIANT FOR INCREASING DOSE INTENSITY OF CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH CANCER
#7091USE OF POLYPEPTIDE IN DRUG FOR PREVENTING AND TREATING PNEUMONIA
#7092PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
#7093BOYSENBERRY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
#7094PHARMACEUTICAL COMPOSITIONS
#7095COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM
#7096Biopolymer compositions for the treatment and prevention of gastric ulcers
#7097FOLLICULAR FLUID METHOD
#7098NATURAL KILLER CELLS
#7099METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION
#7100Methods for treating pulmonary non-tuberculous mycobacterial infections
#7101MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS
#7102COMPOSITION AND TREATMENT FOR CANCER WITH MUTATIONS
#7103ACTIVE AGENT COMBINATION FOR TREATMENT OF CANCER
#7104Substituted indole Mcl-1 inhibitors
#7105Antiproliferative compounds and second active agents for combined use
#7106Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
#7107COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PULMONARY HYPERTENSION
#7108Methods for treating chronic obstructive pulmonary disease
#7109METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#7110SENOLYTIC COMPOUNDS AND COMPOSITIONS
#7111SEMIFLUORINATED ALKANE COMPOSITIONS
#7112METHOD FOR MODULATING WEIGHT
#7113Methods of treatment of cholestatic diseases
#7114TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS
#7115THE ANTIVIRAL DRUG TILORONE IS A POTENT AND SELECTIVE INHIBITOR OF ACETYLCHOLINESTERASE
#7116Levodopa infusion solution
#7117SELF-ASSEMBLED COMPLEX CONTAINING CALCIUM ION
#7118METABOLIC THERAPY OF CANCER
#7119METHODS AND COMPOSITIONS FOR TARGETING CYTOSOLIC DSDNA SIGNALING IN CHROMOSOMALLY UNSTABLE CANCERS
#7120METHOD FOR DETERMINING A VIRALLY-INFECTED SUBJECT'S RISK OF DEVELOPING SEVERE SYMPTOMS
#7121DETERMINING CANCER RESPONSIVENESS TO TREATMENT
#7122DETECTION AND TREATMENT OF AUTISM SPECTRUM DISORDERS
#7123Targeted Gene Therapies for Pain and Other Neuro-Related Disorders
#7124NOVEL TLR9 AGONISTS
#7125Bi-Specific Fusion Proteins
#7126METHODS FOR TREATING MULTIPLE SCLEROSIS WITH OCRELIZUMAB
#7127IL10 receptor binding molecules and methods of use
#7128ANTI-CD93 CONSTRUCTS AND USES THEREOF
#7129EGFR x CD28 MULTISPECIFIC ANTIBODIES
#7130MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF
#7131ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF
#7132COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS
#7133N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors
#7134HETEROCYCLIC GLP-1 AGONISTS
#7135ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF
#7136QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
#7137MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN
#7138Inhibitors of protein tyrosine phosphatase, compositions, and methods of use
#7139COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE
#7140SURFACE-TREATED HYDROTALCITE, SUSPENSION OF SAME, AND FUNCTIONAL MOLECULE DELIVERY SYSTEM USING SAME
#7141PROTOCOL FOR MINIMIZING TOXICITY OF COMBINATION DOSAGES AND IMAGING AGENT FOR VERIFICATION
#7142NUCLEIC ACID THERAPY FOR DIFFERENTIAL MODULATION OF HOST MICROFLORA
#7143ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
#7144AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT
#7145BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF
#7146METHODS OF TREATING GENERALIZED PUSTULAR PSORIASIS (GPP) USING IL-17 ANTAGONISTS
#7147MODIFIED MYCOBACTERIUM BOVIS VACCINES
#7148TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#7149USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
#7150PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMES
#7151THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, AND ASSOCIATED BIOMARKERS BASED ON TRK-B
#7152POLYPHARMACEUTICAL DRUG COMPOSITIONS AND RELATED METHODS
#7153COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS
#7154MICROBIAL STRAINS AND ANTIBIOTICS
#7155COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF
#7156CYTOKINE STORM SUPPRESSOR, METHOD FOR USING CYTOKINE STORM SUPPRESSOR AND SCREENING METHOD
#7157COMPOSITION AND METHOD OF APPLYING SAME TO INCREASE SURVIVAL OF FISH FOLLOWING CATCH-AND-RELEASE SITUATIONS
#7158NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF AN ANTINEOPLASTIC-INDUCED TOXICITY
#7159Micronutrient combination to inhibit coronavirus cell infection
#7160COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES INCLUDING ANTI-TUMOR EFFECTS
#7161INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LasB
#7162PHARMACEUTICAL COMPOSITIONS COMPRISING MACROLIDE DIASTEREOMERS, METHODS OF THEIR SYNTHESIS AND THERAPEUTIC USES
#7163Therapeutically active compounds and their methods of use
#7164METHODS AND COMPOSITIONS FOR TREATING ABNORMAL CELL GROWTH
#7165COMBINATION THERAPIES WITH OLIG2 INHIBITORS
#7166SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES
#7167COMPOUND FOR USE IN THE TREATMENT OF DRY MOUTH
#7168MASITINIB FOR THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER
#7169COMPOSITIONS AND METHODS FOR TREATING METABOLIC DYSREGULATION
#7170Eye-soothing Externally-applied Liquid Medicine and Preparation Method Therefor
#7171DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES
#7172PREVENTATIVE TREATMENT OF MIGRAINE
#7173COMPOSITIONS AND METHODS TO REDUCE NEUROINFLAMMATION
#7174TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES
#7175(1R,3S)-3-((5-CYANO-4-PHENYLTHIAZOL-2-YL)CARBAMOYL)CYCLOPENTANE-1-CARBOXYLIC ACID AND DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF AIRWAY DISEASES
#7176ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF
#7177ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS
#7178Lasofoxifene treatment of aromatase-resistant ER+cancer
#7179Short-acting psychoactive compounds of the MDMA class
#7180ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#7181APPLICATION OF REGULATION OF EYE SCLERA LIPID METABOLISM TO INHIBIT MYOPIA
#7182METHODS OF NORMALIZING AMINO ACID METABOLISM
#7183ACIDIC CANNABINOIDS AND USES THEREOF FOR ENHANCING FEMALE SEXUAL FUNCTION OR TREATING FEMALE SEXUAL DISORDERS
#7184Mirdametinib treatment
#7185PHARMACOKINETICS OF NMDA RECEPTOR ANTAGONISTS
#7186MAGNETOELECTRIC NANOCOMPOSITES AND METHOD OF PREPARATION THEREOF
#7187SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR
#7188SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS
#7189DIAGNOSIS AND TREATMENT OF CANCER
#7190METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#7191BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY
#7192MULTIFUNCTIONAL IMMATURE DENTAL PULP STEM CELLS AND THERAPEUTIC APPLICATIONS
#7193POLYMERS AND USES THEREOF
#7194PROCESS FOR THE PREPARATION OF ALKOXYLATES COMPOSITIONS
#7195Compositions and methods comprising anti-NRP2 antibodies
#7196CD33-binding polypeptides and uses thereof
#7197Method of Treating Psoriasis with IL-23 Specific Antibody
#7198CD28 COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR THERAPY
#7199NOVEL COMPOUNDS WITH ANTIBACTERIAL AND ANTI VIRAL ACTIVITIES
#7200IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS